Connecting the dots: EDEN validation and partnerships

In this video, we talk about the validation of Evaxion’s AI platform EDEN™ and what this means for designing novel vaccine and we’re not the only ones to see the potential in EDEN™. With EDEN™ as a central component, we have entered two new partnerships targeting bacterial targets for which there currently are no vaccines available.

Watch as Evaxion founder Andreas Holm Mattson talks about these exciting developments.